|
Q2 FY2026
As of Jul 4, 2026
|
Q1 FY2026
As of Apr 4, 2026
|
Q4 FY2025
As of Jan 3, 2026
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 1, 2022
|
Q2 FY2022
As of Jul 2, 2022
|
Q1 FY2022
As of Apr 2, 2022
|
Q4 FY2021
As of Jan 1, 2022
|
Q3 FY2021
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts and notes receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Customer relationships, net | ||||||||||||||||||||
| Trade names, net | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Long-term assets held for sale | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND SHAREOWNERS' EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Post-retirement benefits | ||||||||||||||||||||
| Long-term liabilities held for sale | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Shareowners’ Equity | ||||||||||||||||||||
| Common stock, par value $2.50 per share: Authorized 300,000,000 shares in 2026 and 2025 Issued 176,902,738 shares in 2026 and 2025 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Stockholders' equity subtotal | ||||||||||||||||||||
| Less: cost of common stock in treasury (25,889,498 shares in 2026 and 21,866,327 shares in 2025) | ||||||||||||||||||||
| Total Shareowners’ Equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total Liabilities and Shareowners’ Equity | ||||||||||||||||||||
Loading...
